Kotra’s long-term ROE expected to hold steady

PETALING JAYA: Kotra Industries Bhd could see its short-term core profit fall in tandem with slower revenue growth due to weak demand for over-the-counter (OTC) supplements post-pandemic, says CGS-CIMB Research.

With local OTC supplement sales falling back to pre-Covid-19 levels, the research firm said it has cut its core net profit forecast for Kotra by 15.7% in the forecast financial year ending June 30, 2024 (FY24) and 19.2% in FY25 on lower local revenue growth.